LOGIN  |  REGISTER
Amneal Pharmaceuticals
C4 Therapeutics

Molina Healthcare Announces Third Quarter 2024 Earnings Release and Conference Call Dates and Investor Day Meeting

September 09, 2024 | Last Trade: US$294.73 1.21 0.41

LONG BEACH, Calif. / Sep 09, 2024 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318.

A live broadcast of Molina Healthcare’s conference call will be available on the Company’s investor relations website, investors.molinahealthcare.com. A 30-day online replay will be available shortly following the conclusion of the live broadcast.

2024 Investor Day

The Company also announced it will host its 2024 Investor Day meeting on Friday, November 8, 2024, in New York City. The publicly webcast event will begin at 9:30 a.m. Eastern Time.

In-person attendance is by invitation only. All others are invited to register for the event on the Company’s investor relations website at investors.molinahealthcare.com, or directly via the following link: Molina Investor Day Meeting 2024. A 30-day online replay of the Investor Day meeting will be available shortly following the conclusion of the live webcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com.

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB